Actively Recruiting
Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
Led by Next Biomedical Co., Ltd. · Updated on 2025-11-19
72
Participants Needed
3
Research Sites
93 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Study in patients with knee osteoarthritis treated by embolization using NBGM200
CONDITIONS
Official Title
Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Osteoarthritis confirmed by MR imaging
You will not qualify if you...
- Current local infection
- Life expectancy less than 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University Hospital Ghent
Ghent, Belgium
Actively Recruiting
2
Uz Leuven
Leuven, Belgium
Actively Recruiting
3
Elisabeth-Tweesteden Hospital
Tilburg, Netherlands
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here